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ABSTRACT
Objective To explore parent and staff views on the 
acceptability of a randomised controlled trial investigating 
temperature thresholds for antipyretic intervention in 
critically ill children with fever and infection (the FEVER 
trial) during a multi- phase pilot study.
Design Mixed methods study with data collected at three 
time points: (1) before, (2) during and (3) after a pilot trial.
Setting English, Paediatric Intensive Care Units (PICUs).
Participants (1) Pre- pilot trial focus groups with pilot 
site staff (n=56) and interviews with parents (n=25) 
whose child had been admitted to PICU in the last 3 years 
with a fever and suspected infection, (2) Questionnaires 
with parents of randomised children following pilot trial 
recruitment (n=48 from 47 families) and (3) post- pilot trial 
interviews with parents (n=19), focus groups (n=50) and a 
survey (n=48) with site staff. Analysis drew on Sekhon et 
al’s theoretical framework of acceptability.
Results There was initial support for the trial, yet some 
held concerns regarding the proposed temperature 
thresholds and not using paracetamol for pain or 
discomfort. Pre- trial findings informed protocol changes 
and training, which influenced views on trial acceptability. 
Staff trained by the FEVER team found the trial more 
acceptable than those trained by colleagues. Parents and 
staff found the trial acceptable. Some concerns about pain 
or discomfort during weaning from ventilation remained.
Conclusions Pre- trial findings and pilot trial experience 
influenced acceptability, providing insight into how 
challenges may be overcome. We present an adapted 
theoretical framework of acceptability to inform future trial 
feasibility studies.
Trial registration numbers ISRCTN16022198 and 
NCT03028818.
INTRODUCTION
Recruitment and retention in clinical trials is 
a significant challenge, which leads to under-
powered trials and the continued use of health-
care interventions that are not informed 
by robust scientific evidence.1–3 Paediatric 
clinical trials are particularly challenging to 
conduct due to ethical and practical consid-
erations that are not applicable to trials in 
adult settings.4–8 For example, the eligible 
population is smaller and consent is obtained 
by proxy through children’s parents or legal 
guardians.4 9–11 These considerations are 
compounded in critical care settings by the 
emotive and time sensitive situation in which 
they take place. Clinical trials must be accept-
able to parents and healthcare practitioners 
to facilitate recruitment, adherence and 
consent.12 13 Sekhon et al’s13 present a theo-
retical framework of acceptability (TFA) (see 
figure 1) to assist researchers in assessing 
the acceptability of healthcare interventions, 
including clinical trials. The TFA presents 
seven theoretical constructs for researchers 
to consider when assessing whether people 
delivering or receiving a healthcare inter-
vention consider it to be appropriate. The 
constructs highlight considerations when 
establishing acceptability, such as how an 
Strengths and limitations of this study
 ► The longitudinal design enabled collection of data 
from parents and staff with relevant experience be-
fore, during and after the pilot trial.
 ► The mixed methods approach, including interviews, 
focus groups and surveys, enabled breadth and 
depth of insight to help establish trial feasibility.
 ► Use of the Sekhon et al’s theoretical framework of 
acceptability allowed trial acceptability to be eval-
uated as a multifaceted construct as opposed to a 
poorly defined binary (acceptable/not acceptable) 
approach.
 ► Data collected during the pilot trial stage were lim-
ited to parent perspectives, the majority of whom 
were mothers, although staff views were sought 
retrospectively.
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individual feels about the healthcare intervention, the 
perceived burden of taking part and the extent to which 
the participant understands the healthcare intervention 
and how it works.
There is a lack of robust evidence or guidance to inform 
the management of fever due to an infection in critically 
ill children.14 15 The FEVER feasibility study aimed to 
establish whether it is possible to conduct a hospital- based 
clinical trial comparing a permissive approach (treat at 
≥40°C) with a restrictive approach (treat at ≥37.5°C) to 
fever management in children. Perceived challenges to 
the successful conduct of a fever randomised control 
trial (RCT) included: a protocol that was likely to differ 
from usual clinical practice; potential parental and staff 
concerns about allowing a child’s fever to rise without 
treatment; no time to seek informed consent16 17 and the 
possibility that children may die before trial participation 
is discussed with parents.
The FEVER feasibility study involved a multi- phase pilot 
study, including pre- trial research with parents and staff, 
an observation of UK practice and a subsequent pilot 
RCT with embedded research exploring the perspectives 
of parents and staff involved in the pilot RCT.18–20 This 
paper focuses on research exploring parent and staff 
perspectives on trial acceptability drawing on the TFA.
METHODS
Study design
As part of the wider FEVER feasibility study (see figure 2), 
we conducted mixed methods research involving inter-
views, focus groups and surveys with parents who had 
relevant experience and staff involved in the pilot RCT. 
The research reported in this paper was conducted 
before, during and after the pilot RCT and aimed to 
explore parent and staff views on the proposed FEVER 
trial, including trial acceptability, design of informa-
tion materials, temperature thresholds and the use of 
research without prior consent (RWPC). The pilot RCT 
took place over a 3- month period (October–December 
2017). Children were randomly allocated (1:1) without 
prior consent to permissive (39.5°C) or restrictive 
Figure 1 Sekhon et al’s theoretical framework of acceptability.
Figure 2 Fever feasibility study design. *reported separately. 
PICUs, Paediatric Intensive Care Units; RCT, randomised 
control trial.
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(37.5°C) temperature thresholds for antipyretics during 
their Paediatric Intensive Care Unit (PICU) stay while 
mechanically ventilated.19 We used previous research 
that had explored patient and staff perspectives on trials 
conducted in paediatric emergency and critical care in 
the NHS21–23 to develop topic guides for interviews and 
focus groups, questionnaires and participant information 
sheets (PIS).
Patient and public involvement
Two parents (Clara Francis and JW) and one young adult 
(BF) with experience of severe infection and admission to 
hospital were co- investigators and members of the Study 
Management Group. They provided valuable input into 
the design and conduct of the study, including reviewing 
documents for parent interviews (eg, draft pilot trial PIS) 
and informing study recruitment approaches (ie, identi-
fication of social media groups and charities). They were 
also involved in the review of study progress and findings.
Pre pilot trial: prospective recruitment and conduct
Parent interviews
English- speaking parents of children (under 16 years) 
that had been admitted to an intensive care unit with a 
fever and infection in the last 3 years were recruited via 
a database from a previous relevant study24; a letter from 
study sites19 and advertising on relevant social media 
and at sites. Some leniency was allowed if the child was 
admitted close to 3 years prior to interview (eg, 3 years 
and 2 months). All routes invited parents to register 
interest in participation by contacting the research team.
Psychologist ED (PhD, female research associate) 
responded to parents’ requests to participate in sequen-
tial order and checked eligibility. A draft pilot RCT PIS was 
emailed to parents prior to interview, which included an 
outline of the study and current practice on the manage-
ment of fever in critically ill children. ED conducted 
interviews in person or via telephone based on parent 
preference. Audio- recorded verbal or written consent was 
sought before interviews as appropriate. Audio consent 
involved reading each aspect of the consent form to 
parents, including consent for audio recording and to 
receive a copy of the findings when the study is complete. 
Each box was initialled on the consent form when verbal 
consent was provided. Informed consent discussions 
were audio recorded for auditing purposes. Interviewing 
stopped when data saturation25 and variation in sample 
was reached.
Staff focus groups
Co- investigators at the four pilot RCT sites19 disseminated 
invitations to all staff who would be involved in the conduct 
of a clinical trial within a PICU. KW (PhD, female, social 
scientist and a senior lecturer) or ED provided a PIS 
and obtained written informed consent before the focus 
group began. The topic guide consisted of a mix of open- 
ended and closed- ended questions. Closed- ended ques-
tions were administered using the Turning Technologies 
(Youngstown, Ohio, USA) voting system. This allowed 
for the collection of staff demographic information, to 
ensure data collection from all staff on key questions, 
such as views on trial acceptability. The use of Turning 
Point also enabled us to show grouped findings for closed- 
ended questions on a screen to explore reasons for views 
in more depth verbally during the discussion.
Pilot RCT: concurrent and retrospective recruitment and 
conduct
Interim analysis of prospective data informed subsequent 
topic guides and questionnaires.
Parent questionnaire and interviews
As part of the pilot RCT consent discussions, site 
researchers asked both parents if they would like to 
complete the FEVER consent questionnaire after the pilot 
RCT recruitment discussion (concurrent) and/or take 
part in a telephone interview approximately a month later 
(retrospective). In addition to collecting minimal demo-
graphic information, the consent questionnaire asked 
them to indicate how strongly they agreed or disagreed 
with 12 statements about the FEVER RCT followed by tick 
box and open- ended responses regarding their consent 
decision. ED contacted those who consented to interview 
in sequential order (by receipt of a consent form), strati-
fying by study arm (lower/higher temperature threshold) 
as the study progressed ensuring parents whose children 
had been randomised to both trial arms were represented 
in the sample.
Staff survey and focus groups
At the end of the pilot RCT, ED repeated focus groups 
with staff at the four pilot RCT sites to explore their expe-
riences of pilot trial conduct and views on the proposed 
trial acceptability. Those unable to attend a focus group 
were invited by email to complete an online question-
naire containing the same closed- ended questions admin-
istered to focus group participants using the Turning 
Technologies voting system.
Analysis
Digital audio recordings were transcribed verbatim by 
a professional transcription company (Voicescript Ltd, 
Bristol, UK). Transcripts were anonymised and checked 
for accuracy.
ED and KW used a thematic analysis approach26 to 
explore themes within the data related to views on trial 
design and acceptability (see table 1). Analysis was inter-
pretive and iterative.26 27 NVivo V.10 software (QSR Inter-
national Pty Ltd, Melbourne, Australia) was used to assist 
in the organisation and coding of qualitative data. Quan-
titative data from the parent and staff questionnaires were 
entered into SPSS V.20.0 and analysed using descriptive 
statistics. Please see separate publication for further 
details.19 ED and KW then synthesised data and used 
framework analysis28 to map findings onto each compo-
nent of the TFA by time point13 (see tables 2–4). Where 
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illustrative quotes are provided, the participant identifier 
relates to each participant (eg, P01 is participant 1).
RESULTS
Participant characteristics
Prospective (pre- pilot RCT): 25 semi- structured inter-
views (n=20 mothers, n=5 fathers) with bereaved (n=6) 
and non- bereaved (n=19) parents (see figure 3). Parents 
were interviewed a median of 14 months (range: 6–38 
months) after admission. Interviews took a median of 
48 min (range: 15–105 min). The 15- minute interview 
was concluded part way through by a bereaved father. 
Fifty- six staff took part in six focus groups across the four 
sites, lasting a median of 50 min (range: 31–59 min). Staff 
mainly self- identified as nurses (n=45, 81%) were involved 
in the clinical care of children.
Concurrent (during- pilot RCT): 80 parents of the 
100 children randomised to the pilot RCT consented 
to receive questionnaire, of these, 48 from 47 families 
completed and returned a questionnaire while their child 
was admitted to hospital. Of these, 41/48 (85%) provided 
consent and 6/48 (13%) declined consent (n=1 missing).
Retrospective (post- pilot RCT): 66 parents of the 100 
children randomised to the FEVER pilot trial consented 
to be contacted for an interview. Data saturation25 was 
reached after 8 interviews with parents of children allo-
cated to the restrictive (lower) temperature threshold and 
after 11 interviews with parents of children allocated to 
the permissive (higher) temperature threshold. Parents 
were interviewed a median of 31 days after randomisation 
(range: 9–70 days). Their children had received treat-
ment for respiratory illness (eg, bronchiolitis and respi-
ratory syncytial virus) (n=18/19, 94%), cancer (n=1/19, 
5%) and septic shock (n=1/19, 5%). Interviews took an 
average of 32 min (range: 20–50 min).
The staff sample included 98 site staff across all four 
pilot RCT sites. Almost half (48/98, 49 %) completed 
the questionnaire, with the rest attending a focus group. 
The majority (n=75, 77%) were nurses, n=45 (60%), were 
senior- level staff and most (n=79/98, 81%) were involved 
in the clinical care of children. Focus groups took an 
average of 53 min (range: 23–106 min).
Pre-trial, prospective acceptability
All parents interviewed described how they would hypo-
thetically consent for the use of their child’s information 
in the proposed trial. Parents’ views on trial acceptability 
appeared to be influenced by factors, including all other 
treatments for infection are given (opportunity costs); 
the non- invasive nature of the intervention (burden); 
support for RWPC in this context (ethicality); trust in 
medical staff to act in the best interests of their child and 
a belief that the trial question made sense and, therefore, 
likely to achieve its purpose (perceived effectiveness):
‘cause fever is meant to be like part of a fighting off, 
healing process isn’t it? A natural one… I can under-
stand exactly why it would be interesting to see what 
happens.’ (P07, mother, non- bereaved)
Although analysis of pre- RCT data indicated that many 
of the constructs of acceptability were met (see table 2), 
there were also aspects of burden, opportunity costs, ethi-
cality and intervention coherence identified as problem-
atic by both parents and staff. As listed in table 2, staff 
concerns outweighed support at this stage.
The majority of parents were not worried about the 
proposed restrictive temperature threshold of 37.5°C. 
However, staff expressed concerns that this was too low 
a threshold to administer an antipyretic (n=43/54, 80%, 
two missing) and would go against perceived ‘normal 
practice’ (P01, Staff, FG4). A common concern was that 
Table 1 Approach to thematic qualitative data analysis
Phase Description
1. Familiarising with data ED and KW read and re- read transcripts noting down initial ideas on themes.
2. Generating initial codes Two complementary data- coding frameworks were developed (one focus group data (KW) and 
one interview data (ED)) using a priori codes identified from the project proposal and topic guilds. 
During the familiarisation stage ED and KW identified additional data- driven codes and concepts 
not previously captured in the initial coding frame.
3. Developing the coding 
framework
KW coded 10% of the interview transcripts using the initial coding frame and made notes on any 
new themes identified and how the framework could be refined. In turn, ED coded 10% of the 
focus group transcripts following the same procedure.
4. Defining and naming 
themes
Following review and reconciliation revised coding frames were subsequently developed and 
ordered into themes.
5. Completion of coding of 
transcripts
ED completed coding interview transcripts and KW completed coding focus group transcripts in 
preparation for write- up.
6. Producing the report ED and KW developed the original manuscript using themes to relate back to the study aims 
ensuring key findings and recommendations were relevant to the FEVER trial design and 
site staff training (ie, catalytic validity). Final discussion and development of selected themes 
occurred during the write- up phase.
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children would be given unnecessary treatments in a clin-
ical context where ‘we try and give the minimum amount 
of drugs’ (P02, Staff, FG5) (affective attitude).
In contrast, many parents voiced concerns about the 
acceptability of the permissive threshold with regards to 
increased risk of ‘seizures’ (P03, mother, non- bereaved) 
and other potential detrimental side effects (opportunity 
costs), such as ‘organs shutting down’ (P07, mother, non- 
bereaved), ‘rigour’’ (P06, mother, bereaved) or unnec-
essary discomfort (burden). The majority suggested that 
the pilot RCT would be more acceptable if the permis-
sive temperature threshold was slightly lower (eg, 39.9°C 
or 39.5°C). Although parents stated that they would still 
consent to a trial involving a threshold of 40°C (affective 
attitude), as they trusted staff to monitor their child and 
act in their best interests:
‘I would trust that my child was being monitored, it’s 
not like they’re waiting for her condition to get worse 
before they do something, you are having, a nurse by 
your bedside at all times, I had complete trust.’ (P25, 
mother, non- bereaved)
Staff also described how a permissive threshold of ≥40°C 
was too high and how they would be concerned about 
not using paracetamol for analgesia in the less unwell, 
spontaneously breathing patients, who may be in pain or 
discomfort (burden). In addition, staff were concerned 
about parental acceptability of the permissive threshold, 
RWPC (ethicality and opportunity costs) and the impact 
of increased cardiac workload (opportunity costs).
Both groups understood the aims of the proposed 
trial. However, in addition to changes to temperature 
thresholds, amendments to the protocol were suggested. 
Parents identified aspects of the PIS that required clar-
ification, including whether not treating a temperature 
could cause a seizure, incorporating an explanation 
of how all other treatments would still be given. Staff 
requested additional information about the scientific 
evidence underpinning the research question, as well as 
clarification on key issues, such as what cooling methods 
could be used.
Response to pre-trial findings
Pre- trial findings were used in conjunction with observa-
tion study findings19 to develop the pilot RCT protocol 
and site training. These included a permissive tempera-
ture threshold of ≥39.5°C; inclusion criteria that required 
patients to be mechanically ventilated, therefore, likely to 
be on other analgesia and changes to information mate-
rials. For example, staff training and PIS incorporated 
evidence to demonstrate how fever does not cause seizures 
and observation study findings that showed the restrictive 
temperature threshold (≥37.5°C) falls within usual prac-
tice. To address staff concerns about how parents may 
respond to trial and RWPC discussions, parent perspec-
tives were communicated in site training, highlighting 
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parents’ questions about the study and suggestions on 
how to address such questions.
Concurrent acceptability
As demonstrated in table 3, parent questionnaire data 
showed that the six constructs of acceptability measured 
during this time point were met. Parents reported that 
the study information ‘was clear and straightforward to 
understand’ (intervention coherence). Ninety- two per 
cent of randomised children received consent for their 
continued participation in the pilot RCT (affective atti-
tude).19 Main reasons for providing consent related to the 
belief that participation might help their child (n=30/41, 
73%, perceived effectiveness) and help other children in 
the future (n=32/41, 78%, ethicality). Parents also found 
the study acceptable because ‘my child was comfortable’ 
(P49, questionnaire, mother, permissive) (opportunity 
costs and burden).
Of the eight that refused consent to continue, seven 
(88%) had been allocated to the permissive (higher) treat-
ment group. Data suggested that parents who declined 
some element of their child participation still supported 
the proposed FEVER RCT. Reasons for refusal of consent 
were linked to pre- existing medical conditions and the 
wish to limit any discomfort experienced by their child: 
‘My son had too many underlying medical conditions 
and felt it may hinder his recovery as he was selected to 
the upper limit’ (P73, questionnaire, father, permissive). 
Suggesting that there were still some concerns about with-
holding analgesia (opportunity costs).
Staff acceptability was not measured at this point.
Post-trial, retrospective acceptability
Interviews conducted with parents a median 1- month 
post- randomisation supported and provided further 
insights into questionnaire findings. All seven constructs 
of acceptability were met (see table 4). Parents were inter-
ested in the trial question and felt the proposed trial was 
important (affective attitude and perceived effectiveness). 
Parents described staff as approaching them appropri-
ately, with well- timed, clear, comprehensive study infor-
mation leading to strong intervention coherence:
‘I understood what they were saying and was happy to 
sort of go ahead, with the trial. If it wasn’t explained 
to me too well, I probably wouldn’t have bothered 
doing it.’ (P77, interview, father, restrictive) (inter-
vention coherence)
Parents of children allocated to the restrictive temper-
ature threshold found the trial very acceptable as giving 
paracetamol at this temperature was ‘something that I 
would do myself anyway’ (P82, interview, father, restric-
tive) (ethicality). Parents also viewed the permissive 
threshold to be acceptable. However, this acceptability 
was conditional on their child not being in discomfort 
(pportunity costs):
‘The only thing would be if she wasn’t on any other 
kind of pain relief, but there’s other things to manage, 
her discomfort.’ (P73, interview, father, permissive)
Indeed, two mothers described how they found the 
trial acceptable and gave full consent, but later chose to 
withdraw their child from the study when they were being 
weaned from ventilation and sedation due to concerns 
about their child being in pain or distress. Parents valued 
the ability to withdraw or decline consent (self- efficacy). 
They also described how they trusted staff to act in their 
child’s best interests, including not adhering to the 
protocol by administering an antipyretic if at any point 
staff felt that it was needed (burden and opportunity 
costs):
‘I know if anything did happen, you’s can stop at any 
time. Stop it if they saw it was getting out of hand and 
he, and I felt like it, it wasn’t helping, that I would 
stop it.…they wouldn’t let him go to the stage of him 
getting poorly.’ (P85, interview, father, restrictive)
Unlike parents’ views, which largely remained consistent 
across study time points, staff perceptions of the accepta-
bility of the lower temperature shifted during the course 
of the pilot RCT. Witnessing patient’s positive reactions 
to RWPC and trial discussions and an awareness that 
≥37.5°C was usual practice, resulted in 95% (n=95/100, 
four missing) of staff rating the restrictive threshold as 
acceptable or very acceptable: ‘Everybody that was in the 
lower end of it, I found were like happy to take part’ (P01, 
Staff, FG4).
Figure 3 Participant characteristics by time point. RCT, 
randomised control trial.
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Staff had mixed views about the acceptability of the 
permissive temperature threshold. Approximately half 
(n=42/79, 53%) indicated that the ≥39.5°C threshold was 
acceptable. They valued how the trial team responded to 
their pre- trial concerns by changing the inclusion criteria 
to omit non- ventilated children (self- efficacy). Some 
stated that their previous concerns about high tempera-
tures causing harm or discomfort (opportunity costs) and 
parents having a negative response to the trial and RWPC 
(ethicality) were not observed:
‘Some patients are randomised into the higher tem-
perature and people see that they’re actually manage-
able and it doesn’t cause them any harm… It’s kind 
of seeing is believing.’ (P03, Staff, FG1)
Staff who did not find the permissive temperature 
acceptable were concerned about not giving paracetamol 
for pain or discomfort when a child was conscious (oppor-
tunity costs). These concerns meant that some staff 
administered paracetamol before a child’s temperature 
had reached ≥39.5°C: ‘I feel like potentially we’re making 
our patients more uncomfortable’ (P01, Staff, FG2).
Interestingly, staff trained by their local unit colleagues 
were significantly more likely to find the permissive 
threshold not acceptable when compared with those 
trained directly by the pilot trial team (χ2(2)=8.78, 
p=0.012). Staff trained colleagues also rated site training 
as being poor (n=11/97, 11%). These staff remained 
unclear about the scientific rationale for the study and 
had lower intervention coherence.
Despite issues with aspects of intervention coherence 
and opportunity costs, overall staff rated the fever trial 
acceptable (n=81/95, 85%, affective attitude) and practi-
cable to conduct (n=80/95, 84%, self- efficacy). Findings 
suggest that their views could be further augmented if the 
proposed FEVER RCT protocol was revised to also exclude 
patients receiving non- invasive forms of ventilation (eg, 
high- flow nasal oxygen) or those close to being extubated 
when sedation is being weaned.
Trust
During data analysis, we found that the concept of trust 
between parents and staff was prevalent within our data 
and intrinsically linked to trial acceptability. For example, 
parents found the trial acceptable because they trusted 
staff to put the needs of their child before the requirements 
of the study. Both groups discussed the trust parents place 
in medical expertise during a very emotive situation. Staff 
also highlighted that maintaining parental trust impacts 
on their decisions: ‘I feel like there’s an element of trust 
there that would be broken from my point of view’ (P01, 
Staff, FG2, retrospective). The construct of ‘Trust’ is not 
reflected within the TFA. We present an adapted TFA in 
figure 4 incorporating Trust.
DISCUSSION
Our study highlights the value of conducting pre- trial 
research with key stakeholders to inform the design of 
challenging clinical trials.29 Research with parents and 
staff helped establish trial acceptability, as well as influ-
ence and changed perspectives over time. Prospective 
qualitative research identified mixed staff views, while 
parents found the trial broadly acceptable. Both the 
parental and staff support for RWPC in time critical 
trials is constant with previous research.24 30–34 Aspects of 
intervention coherence, opportunity costs, ethicality and 
burden13 were identified that threatened trial success. 
The majority of staff concerns related to not using parac-
etamol or active cooling for pain relief, or to prevent 
febrile seizures.18 Prospective findings informed changes 
to the PIS, staff training package and the addition of 
mechanical ventilation to inclusion criteria. Data from 
the concurrent and retrospective time points showed a 
positive response to such changes, particularly among 
Figure 4 The adapted theoretical framework of acceptability.
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staff. Suggestions to further augment views on trial accept-
ability and reduce the number of potential protocol devi-
ations and withdrawals were identified. These include 
changes to trial inclusion criteria as well as staff training 
content and delivery.18
Our findings demonstrate Sekhon et al’s assertion that 
the acceptability of healthcare interventions is not a 
fixed construct. If we had taken a binary (acceptable/not 
acceptable) or snapshot approach to determining accept-
ability, then we would not have been able to identify and 
address key concerns that threatened trial acceptability 
and ultimately, trial feasibility. The TFA was demonstrated 
to be comprehensive and relevant to our work. However, 
we found that the concept of trust between parents and 
staff was closely linked to trial acceptability and is not 
reflected in the framework. The importance of trust is a 
recurring theme in healthcare and medicine but is partic-
ularly salient in paediatric trials, as the more vulnerable 
the population, the greater the need for trust.5 35 Drawing 
on Hall et al’s35 work into defining trust in medical rela-
tionships, we propose the addition of an eighth construct 
of ‘Trust’ to help inform future trial feasibility research 
(see figure 4). Further research is needed to test the 
adapted model in establishing the feasibility of other 
healthcare interventions and settings. This work will help 
to establish the appropriateness of trust as additional 
construct in the TFA.
As the pilot trial was conducted in 3 months, during the 
busy winter period, the concurrent work only included 
parents and, therefore, lacks insight into staff perspectives 
during pilot trial conduct. This limitation was compen-
sated for by the use of retrospective (1 week–1 month) 
mixed methods ensuring a larger sample, through the 
survey and depth of insights, through focus groups. 
Insight was gained into the views of 8 (2 interviews, 
six questionnaires) out of 18 parents (44%) who had 
declined their child’s continued participation in one or 
more aspect of the pilot RCT. In particular, the interviews 
with parents who declined consent and nursing staff who 
found the protocol challenging to follow provided valu-
able information to assist with refining the study process 
for a definitive RCT. However, it is unknown whether or 
not the predominantly positive views of the declining 
parents who took part in an interview or questionnaire 
were shared by other parents who declined the FEVER 
pilot RCT.
In summary, challenges to delivering the proposed trial 
included staff and parent concerns about the acceptability 
of the proposed protocol. Pre- trial research, staff training 
and experience of pilot trial conduct augmented views, 
providing insight into how challenges may be overcome, 
such as changes to the inclusion criteria and delivery of 
site training. We present an adapted TFA to inform the 
design of future trial feasibility studies.
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